Reviews and feature article
An update on the genetics of atopic dermatitis: Scratching the surface in 2009

https://doi.org/10.1016/j.jaci.2009.11.008Get rights and content

A genetic basis for atopic dermatitis (AD) has long been recognized. Historic documents allude to family history of disease as a risk factor. Before characterization of the human genome, heritability studies combined with family-based linkage studies supported the definition of AD as a complex trait in that interactions between genes and environmental factors and the interplay between multiple genes contribute to disease manifestation. A summary of more than 100 published reports on genetic association studies through mid-2009 implicates 81 genes, in 46 of which at least 1 positive association with AD has been demonstrated. Of these, the gene encoding filaggrin (FLG) has been most consistently replicated. Most candidate gene studies to date have focused on adaptive and innate immune response genes, but there is increasing interest in skin barrier dysfunction genes. This review examines the methods that have been used to identify susceptibility genes for AD and how the underlying pathology of this disease has been used to select candidate genes. Current challenges and the potential effect of new technologies are discussed.

Section snippets

Genome-wide linkage studies on AD

Given the long-standing recognition of the role of heritability in the manifestation of AD and the characteristic early age of disease onset, AD is a trait highly amenable to the genome-wide linkage approach for identifying novel genes. The genome-wide linkage method is a family-based approach relying on a collection of affected individuals (probands) and their parents (ie, case-parent trio design) or affected sibling pairs and their parents (and often additional family members) for which the

Summary

To recapitulate, AD is a chronic inflammatory disease of the skin characterized by dysregulation of the adaptive and innate immune response and a heightened IgE-mediated, systemic TH2 response. Extreme TH2 polarization and primary defects in the innate immune response, including epithelial barrier defects, in conjunction with mechanical damage to the epidermis as a consequence of the intense pruritus that is the hallmark feature of AD likely contribute to the more severe sequelae, including

References (106)

  • P.J. Hauk et al.

    Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens

    J Allergy Clin Immunol

    (2000)
  • L. Gao et al.

    Polymorphisms in the myosin light chain kinase gene that confer risk of severe sepsis are associated with a lower risk of asthma

    J Allergy Clin Immunol

    (2007)
  • H. Levy et al.

    Association of defensin beta-1 gene polymorphisms with asthma

    J Allergy Clin Immunol

    (2005)
  • I. Matsushita et al.

    Genetic variants of human beta-defensin-1 and chronic obstructive pulmonary disease

    Biochem Biophys Res Commun

    (2002)
  • R.E. Callard et al.

    The skin barrier, atopic dermatitis and allergy: a role for Langerhans cells?

    Trends Immunol

    (2007)
  • S.T. Holgate

    The epithelium takes centre stage in asthma and atopic dermatitis

    Trends Immunol

    (2007)
  • P.M. Elias et al.

    Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms

    J Allergy Clin Immunol

    (2008)
  • J.B. Travers et al.

    The keratinocyte as a target for staphylococcal bacterial toxins

    J Investig Dermatol Symp Proc

    (2001)
  • C.M. Niessen

    Tight junctions/adherens junctions: basic structure and function

    J Invest Dermatol

    (2007)
  • S. Aijaz et al.

    Binding of GEF-H1 to the tight junction-associated adaptor cingulin results in inhibition of Rho signaling and G1/S phase transition

    Dev Cell

    (2005)
  • G.M. O'Regan et al.

    Filaggrin in atopic dermatitis

    J Allergy Clin Immunol

    (2008)
  • C.N. Palmer et al.

    Filaggrin null mutations are associated with increased asthma severity in children and young adults

    J Allergy Clin Immunol

    (2007)
  • N. Novak et al.

    Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel

    J Invest Dermatol

    (2008)
  • Z.R. Lu et al.

    Profiling the dysregulated genes of keratinocytes in atopic dermatitis patients: cDNA microarray and interactomic analyses

    J Dermatol Sci

    (2009)
  • J.E. Gereda et al.

    Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma

    Lancet

    (2000)
  • W.D. Smith

    Hippocrates

    (1994)
  • E. Besnier

    Premier note et observations preliminaire pour service d-introduction a letute des prurigos diathesiques

    Ann Dermatol Syphil

    (1892)
  • A.F. Coca

    Specific diagnosis and treatment of allergic diseases of the skin

    JAMA

    (1934)
  • S. Dold et al.

    Genetic risk for asthma, allergic rhinitis, and atopic dermatitis

    Arch Dis Child

    (1992)
  • I.B. Sneddon

    The management of infantile eczema

    Med Press

    (1951)
  • N. Schaffer

    Atopic dermatitis in the older child

    J Asthma Res

    (1966)
  • M.-L. Edfors-Lubs

    Allergy in 7000 twin pairs

    Acta Allergol

    (1971)
  • F.V. Schultz Larsen et al.

    Atopic dermatitis in a population based twin series. Concordance rates and heritability estimation

    Acta Derm Venereol Suppl (Stockh)

    (1985)
  • F.S. Larsen et al.

    Atopic dermatitis. A genetic-epidemiologic study in a population-based twin sample

    J Am Acad Dermatol

    (1986)
  • C.E. van Beijsterveldt et al.

    Genetics of parentally reported asthma, eczema and rhinitis in 5-yr-old twins

    Eur Respir J

    (2007)
  • A.J. Walley et al.

    Gene polymorphism in Netherton and common atopic disease

    Nat Genet

    (2001)
  • E. Lander et al.

    Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results

    Nat Genet

    (1995)
  • Y.A. Lee et al.

    A major susceptibility locus for atopic dermatitis maps to chromosome 3q21

    Nat Genet

    (2000)
  • W.O. Cookson et al.

    Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci

    Nat Genet

    (2001)
  • M. Bradley et al.

    Susceptibility loci for atopic dermatitis on chromosomes 3, 13, 15, 17 and 18 in a Swedish population

    Hum Mol Genet

    (2002)
  • A. Haagerup et al.

    Atopic dermatitis—a total genome-scan for susceptibility genes

    Acta Derm Venereol

    (2004)
  • M. Guilloud-Bataille et al.

    Evidence for linkage of a new region (11p14) to eczema and allergic diseases

    Hum Genet

    (2008)
  • H. Enomoto et al.

    Single nucleotide polymorphism-based genome-wide linkage analysis in Japanese atopic dermatitis families

    BMC Dermatol

    (2007)
  • U. Christensen et al.

    Linkage of atopic dermatitis to chromosomes 4q22, 3p24 and 3q21

    Hum Genet

    (2009)
  • J.C. Venter et al.

    The sequence of the human genome

    Science

    (2001)
  • C. Ober et al.

    Asthma genetics 2006: the long and winding road to gene discovery

    Genes Immun

    (2006)
  • N. Risch et al.

    The future of genetic studies of complex human diseases

    Science

    (1996)
  • M. Kabesch

    The art of replication

    Thorax

    (2009)
  • A haplotype map of the human genome

    Nature

    (2005)
  • A.J. Rogers et al.

    Assessing the reproducibility of asthma candidate gene associations, using genome-wide data

    Am J Respir Crit Care Med

    (2009)
  • Cited by (257)

    • Basic genetics and epigenetics for the immunologist and allergist

      2022, Allergic and Immunologic Diseases: A Practical Guide to the Evaluation, Diagnosis and Management of Allergic and Immunologic Diseases
    • Autoantigens in atopic dermatitis: The characterization of autoantigens and their diagnostic value

      2022, Translational Autoimmunity: Challenges for Autoimmune Diseases: Volume 5
    View all citing articles on Scopus

    (Supported by an educational grant from Merck & Co., Inc.)

    Series editors: Joshua A. Boyce, MD, Fred Finkelman, MD, William T. Shearer, MD, PhD, and Donata Vercelli, MD

    Supported by the National Institute of Health (National Institute of Allergy and Infectious Diseases: HSN266200400029C).

    Terms in boldface and italics are defined in the glossary on page 17.

    View full text